Discover Tenders by Pharmaceutical Articles Sector

Find the most relevant tenders for Pharmaceutical Articles. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Pharmaceutical Articles tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Pharmaceutical Articles tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6103773

EMD:Ref Document

Bid Value: Ref Document

517 Days Left

Open Framework Agreement On Pharmaceutical Discounts In Accordance With Section 130A Paragraph 8 Of The Social Code Book V With The Option To Join At Any Time So Called Approval Model 2024 01

Deadline: 05 Jan 2026

Germany

Ref. No.: 6102560

EMD:Ref Document

Bid Value: Ref Document

157 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Lisdexamfetamine

Deadline: 10 Nov 2025

Germany

Ref. No.: 6072974

EMD:Ref Document

Bid Value: Ref Document

101 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ustekinumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 6065652

EMD:Ref Document

Bid Value: Ref Document

374 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Lisdexamfetamine

Deadline: 10 Nov 2025

Germany

Ref. No.: 6040123

EMD:Ref Document

Bid Value: Ref Document

101 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Epinephrine In The Dosage Form Ilo

Deadline: 10 May 2026

Germany

Ref. No.: 5978859

EMD:Ref Document

Bid Value: Ref Document

282 Days Left

Conclusion Not Exclusive Of Am Discount Agreement According To Section 130A Paragraph 8 Sgb V By Means Of An Oh Model For Ws Epoetin Alfa Genetically Engineered Human Erythropoietin Restriction To Packs With Doses Up To 10 000 Iu

Deadline: 31 Jul 2026

Germany

Ref. No.: 5978748

EMD:Ref Document

Bid Value: Ref Document

364 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Filgrastim Atc Code According To Who L03Aa02

Deadline: 30 Jun 2026

Germany

Ref. No.: 5978377

EMD:Ref Document

Bid Value: Ref Document

333 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ebastine In The Strength 20 Mg And The Dosage Form Smt

Deadline: 10 May 2026

Germany

Ref. No.: 5978310

EMD:Ref Document

Bid Value: Ref Document

282 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Somatropin Atc Code According To Who H01Ac01

Deadline: 31 Jul 2026

Germany

Ref. No.: 5977915

EMD:Ref Document

Bid Value: Ref Document

364 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brimonidine In The Dosage Form Edp

Deadline: 10 May 2026

Germany

Ref. No.: 5977462

EMD:Ref Document

Bid Value: Ref Document

282 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf

Deadline: 10 May 2026

Germany

Ref. No.: 5976401

EMD:Ref Document

Bid Value: Ref Document

282 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of A So Called Open House Model For Medicinal Products With The Trade Name Acarizax R Atc Code According To Who V01Aa03

Deadline: 31 Jul 2026

Germany

Ref. No.: 5975947

EMD:Ref Document

Bid Value: Ref Document

364 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Pegfilgrastim Atc Code According To Who L03Aa13

Deadline: 30 Apr 2026

Germany

Ref. No.: 5975224

EMD:Ref Document

Bid Value: Ref Document

272 Days Left

Deadline: 31 Jul 2026

Germany

Ref. No.: 5975023

EMD:Ref Document

Bid Value: Ref Document

364 Days Left

Showing 28831 to 28845 of 29060 results

‹
1
2
...
1920
1921
1922
1923
1924
1925
1926
...
1937
1938
›

Discover Tenders by Pharmaceutical Articles Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Pharmaceutical Articles Sector

Filter Your Search

FREE Trial plan for all new users!